Previous studies also suggest that miR‐135a may target IL‐17, and downregulation of miR‐135a promotes nasopharyngeal carcinoma development through IL‐17‐mediated cytokine expression.38 The gene discussed is IL17A; the disease is nasopharyngeal carcinoma.